Department of Chemistry-BMC, Biochemistry, Uppsala University, Uppsala, Sweden.
Bjerking AB Uppsala, Uppsala, Sweden.
FEBS Open Bio. 2020 Dec;10(12):2605-2615. doi: 10.1002/2211-5463.12994. Epub 2020 Nov 2.
Leupeptin is a naturally occurring inhibitor of various proteases, in particular serine proteases. Following its discovery, the inhibitory properties of several other peptidyl argininals have been studied. The specificity of leupeptin is most likely due to the Leu-Leu-Argininal sequence, and its C-terminal aldehyde group has been suggested to enhance the binding efficiency and to be essential for function. The terminal aldehyde group makes the structure less vulnerable to carboxypeptidases. Here, we investigated whether the inhibitory function of leupeptin toward serine proteases is retained after oxidation or reduction of the aldehyde group. The oxidized form, which corresponds to the natural precursor, was shown to be superior to the reduced form in terms of inhibitory properties. However, the original leupeptin possessed enhanced inhibitory properties as compared with the oxidized form. Based on these results, new synthetic leupeptin analogues, 6-aminohexanoic acid (Ahx)-Phe-Leu-Arg-COOH and Ahx-Leu-Leu-Arg-COOH, were prepared by solid-phase peptide synthesis using the Fmoc strategy. In these analogues, the N-terminal capping acetyl group was replaced with a 6-aminohexanoyl group to allow conjugation. The structures of the modified leupeptin and the synthetic peptides were confirmed by mass spectrometry. Determination of the inhibitory properties against trypsin (IEC 3.4.21.4, Chymotrypsin IEC 3.4.21.1) revealed that these further modified tripeptides were tight binding inhibitors to their target enzyme, similar to the naturally occurring leupeptin, with K values generally in the micromolar range. The Ahx-Phe-Leu-Arg-COOH analogue was selected for conjugation to inorganic oxide nanoparticles and agarose gel beads. All conjugates exhibited inhibitory activity in the same range as for the free peptides.
亮抑酶肽是一种天然存在的多种蛋白酶抑制剂,特别是丝氨酸蛋白酶抑制剂。在发现亮抑酶肽之后,人们研究了其他几种肽基精氨酸抑制剂的抑制特性。亮抑酶肽的特异性很可能归因于亮氨酸-亮氨酸-精氨酸序列,其 C 末端醛基被认为可以提高结合效率,并且对功能至关重要。末端醛基使结构不易受到羧肽酶的影响。在这里,我们研究了亮抑酶肽的醛基氧化或还原后对丝氨酸蛋白酶的抑制功能是否保留。氧化形式(对应于天然前体)在抑制特性方面优于还原形式。然而,原始亮抑酶肽与氧化形式相比具有增强的抑制特性。基于这些结果,使用 Fmoc 策略通过固相肽合成制备了新的合成亮抑酶肽类似物 6-氨基己酸(Ahx)-Phe-Leu-Arg-COOH 和 Ahx-Leu-Leu-Arg-COOH。在这些类似物中,用 6-氨基己酰基取代 N-末端封端乙酰基以允许缀合。通过质谱法确认了修饰亮抑酶肽和合成肽的结构。测定对胰蛋白酶(IEC 3.4.21.4,糜蛋白酶 IEC 3.4.21.1)的抑制特性表明,这些进一步修饰的三肽是其靶酶的紧密结合抑制剂,类似于天然存在的亮抑酶肽,K 值通常在微摩尔范围内。选择 Ahx-Phe-Leu-Arg-COOH 类似物与无机氧化物纳米粒子和琼脂糖凝胶珠缀合。所有缀合物的抑制活性均与游离肽相同。